178 related articles for article (PubMed ID: 26189795)
1. Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma.
Satheesha S; Manzella G; Bovay A; Casanova EA; Bode PK; Belle R; Feuchtgruber S; Jaaks P; Dogan N; Koscielniak E; Schäfer BW
Oncogene; 2016 Apr; 35(16):2020-30. PubMed ID: 26189795
[TBL] [Abstract][Full Text] [Related]
2. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
3. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
[TBL] [Abstract][Full Text] [Related]
4. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
[TBL] [Abstract][Full Text] [Related]
6. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.
Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM
Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
10. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage.
Hatley ME; Tang W; Garcia MR; Finkelstein D; Millay DP; Liu N; Graff J; Galindo RL; Olson EN
Cancer Cell; 2012 Oct; 22(4):536-46. PubMed ID: 23079662
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
13. c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells.
Kaspar P; Prochazka J; Efenberkova M; Juhasz A; Novosadova V; Sedlacek R
Sci Rep; 2019 Apr; 9(1):6342. PubMed ID: 31004084
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of posaconazole as a hedgehog/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy.
Sun J; Lin W; Li C; Ueki H; Xue R; Sadahira T; Hu H; Wada K; Li N; Liu C; Araki M; Xu A; Huang P
Am J Cancer Res; 2021; 11(9):4528-4540. PubMed ID: 34659903
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
16. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma.
Almazán-Moga A; Zarzosa P; Vidal I; Molist C; Giralt I; Navarro N; Soriano A; Segura MF; Alfranca A; Garcia-Castro J; Sánchez de Toledo J; Roma J; Gallego S
Stem Cells Int; 2017; 2017():7507380. PubMed ID: 28243259
[TBL] [Abstract][Full Text] [Related]
18. Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma.
Hayes MN; McCarthy K; Jin A; Oliveira ML; Iyer S; Garcia SP; Sindiri S; Gryder B; Motala Z; Nielsen GP; Borg JP; van de Rijn M; Malkin D; Khan J; Ignatius MS; Langenau DM
Cell Stem Cell; 2018 Mar; 22(3):414-427.e6. PubMed ID: 29499154
[TBL] [Abstract][Full Text] [Related]
19. Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.
Tostar U; Toftgård R; Zaphiropoulos PG; Shimokawa T
Genes Cancer; 2010 Sep; 1(9):941-51. PubMed ID: 21779473
[TBL] [Abstract][Full Text] [Related]
20. Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma.
Manzella G; Schäfer BW
Curr Drug Targets; 2016; 17(11):1228-34. PubMed ID: 25944015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
